'Hetero Drugs Ltd ' - 4 News Result(s)
- India News | Reuters | Wednesday June 24, 2020Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
www.ndtv.com
- Business | Thomson Reuters | Thursday March 26, 2015German generics drug maker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
www.ndtv.com/business
- Business | Monday September 15, 2014US drug maker Gilead Sciences Inc on Monday said it has licensed its hepatitis C drug to seven companies including Cipla Ltd and Ranbaxy Laboratories Ltd to make it available in 91 developing countries including India.
www.ndtv.com/business
- Business | Friday February 22, 2013Aurobindo Pharma is preparing to challenge before the Appellate Tribunal an order that allowed Enforcement Directorate (ED) to take possession of attached property and fixed deposits worth Rs 12.90 crore in connection with money laundering probe against YSR Congress chief Jagan Mohan Reddy and his associates.
www.ndtv.com/business
'Hetero Drugs Ltd ' - 4 News Result(s)
- India News | Reuters | Wednesday June 24, 2020Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
www.ndtv.com
- Business | Thomson Reuters | Thursday March 26, 2015German generics drug maker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
www.ndtv.com/business
- Business | Monday September 15, 2014US drug maker Gilead Sciences Inc on Monday said it has licensed its hepatitis C drug to seven companies including Cipla Ltd and Ranbaxy Laboratories Ltd to make it available in 91 developing countries including India.
www.ndtv.com/business
- Business | Friday February 22, 2013Aurobindo Pharma is preparing to challenge before the Appellate Tribunal an order that allowed Enforcement Directorate (ED) to take possession of attached property and fixed deposits worth Rs 12.90 crore in connection with money laundering probe against YSR Congress chief Jagan Mohan Reddy and his associates.
www.ndtv.com/business